Overview of clinical trials of cholesterol lowering in relationship to epidemiologic studies (Q38704422)

5 September 2017

1 reference

title

Overview of clinical trials of cholesterol lowering in relationship to epidemiologic studies (English)

1 reference

5 September 2017

Tyroler HA

1

1 reference

PubMed ID

2679079

5 September 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

American Journal of Medicine

5 September 2017

1 reference

5 September 2017

87

1 reference

5 September 2017

4A

1 reference

5 September 2017

14S-19S

1 reference

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

5 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Review of lipid-lowering clinical trials in relation to observational epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

CORN OIL IN TREATMENT OF ISCHAEMIC HEART DISEASE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

The Oslo diet-heart study. Eleven-year report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Dietary Prevention of Coronary Heart Disease: The Finnish Mental Hospital Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

On a possible inverse relationship between serum cholesterol and cancer mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Ischemic heart disease risk factors and twenty-year mortality in middle-age Evans County black males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Cholesterol and mortality in New Zealand Maoris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Serum cholesterol and mortality: the Yugoslavia Cardiovascular Disease Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980594-7

10.1016/S0002-9343(89)80594-7

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

2679079